Literature DB >> 6892780

Prevention of bacterial respiratory infection by an association of bacterial ribosomes and membranous proteoglycans. 2. Objective assessment of the response and of the immunological stimulation.

F B Michel, L Dussourd d'Hinterland, A M Pinel, R Guendon, A J Guerrero, M Moutou, J P Bansard.   

Abstract

Using a vaccine preparation administered by aerosol for respiratory anti-infectious purposes and corresponding to the original formula of ribosomes and membrane fractions of microbial germs, the authors investigated during a period of nine months whether an objective, transient or lasting stimulation of the total and specific immunoglobulin (Ig) appeared. They provide a statistical analysis based on several serum Ig measurements and demonstrate the stimulant and lasting effect of the vaccine in the production of specific Ig for a sample of patients compared with controls. In those treated they observed apparently disordered variations of the serum levels of the total Ig, which in fact correspond to the initiation of a dynamic equilibrium in relation to the immunogenicity of the vaccine, the initial level of the total Ig and the production of the specific Ig. Finally, after a booster sequence carried out five month after "primary vaccination", they established the restarting of production of specific Ig accompanied this time by a different dynamic response of the total Ig.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6892780

Source DB:  PubMed          Journal:  Arzneimittelforschung        ISSN: 0004-4172


  2 in total

Review 1.  Ribosomal immunotherapy for recurrent respiratory tract infections in children.

Authors:  Marie C Béné; Gilbert C Faure
Journal:  Paediatr Drugs       Date:  2003       Impact factor: 3.022

2.  The polybacterial lysate Olimunostim modulates lymphocyte function in vitro and restores depressed cellular immunity in vivo.

Authors:  M Petrek; E Weigl; M Ordeltová
Journal:  Folia Microbiol (Praha)       Date:  1994       Impact factor: 2.099

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.